Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15497625 | 0.99 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL9921101 | 0.96 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL9921055 | 0.96 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL29500551 | 0.96 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL9920726 | 0.94 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL9920949 | 0.94 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL9920947 | 0.92 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL9920758 | 0.92 | CYP1A2 (0.47) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL9921053 | 0.91 | L3MBTL1 (0.50) | L3MBTL1KDM4EATMCYP1A2ERBB2 | |
| SCHEMBL9920627 | 0.90 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMCYP1A2ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1942171-B1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES (JP) | 2018-04-18 | — | — | EP | disclosed |
| EP-2463351-A2 | Light emitting device material and light emitting device | Toray Industries, Inc. (JP) | 2012-06-13 | — | — | EP | disclosed |
| EP-2463352-A2 | Light emitting device material and light emitting device | Toray Industries, Inc. (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-20090096356-A1 | Light-emitting device material and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090096356-A1 | Light-emitting device material and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-1942171-A1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2008-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090096356-A1 | Light-emitting device material and light-emitting device | PRMT9, CCNL2, MRPL9 | L3MBTL1 283/4885KDM4E 2433/4885ATM 1983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.